BioMarin Pharmaceutical, which is vying to release the most expensive drug in the world at somewhere between $2 million and $3 million a dose, announced Tuesday the departure of its chief financial officer.
Drugmaker BioMarin Seeks New CFO Amid Coming Release Of Potentially Costliest Drug In The World
